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Abstract 
We studied the effects of cyclohexenonic long-chain fatty alcohol (N-hexacosanol) on 
diabetes-induced angiopathy in the rat aorta.  Male Sprague-Dawley rats were divided 
into 4 groups, a control group and 3 other groups in which diabetes was induced by 
streptozotocin (50 mg/kg i.p.).  Four weeks after the induction of diabetes, the 3 
groups received treatment with either vehicle or N-hexacosanol (2 or 8 mg/kg, i.p. every 
day) for another 4 weeks.  To determine the mechanisms of diabetic vascular 
dysfunction and the effects of N-hexacosanol, we conducted organ bath studies and 
real-time polymerase chain reaction on muscarinic M3 receptor, and endothelial and 
inducible nitric oxide synthase (eNOS and iNOS) mRNAs in the rat aorta.  Treatment 
with N-hexacosanol did not alter the diabetic status, but improved the diabetes-induced 
hypercontraction produced by norepinephrine and the damaged endothelium-dependent 
relaxation of the rat aorta induced by acetylcholine.  Furthermore, in the diabetic rats, 
both muscarinic M3 receptor and iNOS mRNAs were significantly increased, and 
N-hexacosanol reversed these upregulations.   However, the expression of eNOS 
mRNA showed no change in all groups.  These results indicate that N-hexacosanol has 
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beneficial effects on functional dysfunction and reverses the upregulation of muscarinic 
M3 
 
receptor and iNOS mRNAs in the diabetic rat aorta. 
Key Words: N-hexacosanol, NOS, muscarinic M3
 
 receptor, aorta, endothelium, diabetes 
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1. Introduction 
  Cardiovascular disease is one of the leading causes of death in diabetes mellitus, 
which alters vascular responsiveness to several vasoconstrictors and vasodilators and is 
a major factor underlying the development of this disease (Senses et al., 2001).  Most 
of the complications in diabetes are caused by increased serum glucose and the 
increased generation of oxygen-derived free radicals, which lead to endothelium 
dysfunction and neuropathy.  Although strict glycemic control delays the onset and 
slows down the progression of diabetic vascular complications (The Diabetic Control 
and Complications Trial Research Group, 1993), this strategy is not successful in all 
patients.  There have been many reports demonstrating functional changes in various 
smooth muscle cells from diabetic animals (Ozturk et al., 1996).  It has been shown 
that vessels from diabetic animals exhibit abnormal endothelium-dependent vascular 
relaxation to acetylcholine (Oyama et al., 1986).  These functional changes may be 
associated with endothelium dysfunction in diabetes.  Impaired 
endothelium-dependent vasodilatation may arise from several mechanisms: decreased 
production of one of the endothelium-derived relaxing factors (EDRFs), including nitric 
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oxide (NO ) and prostacyclin (PGI2), enhanced inactivation of EDRF, impaired 
diffusion of EDRF to the underlying smooth muscle, and enhanced generation of 
endothelium-derived constricting factors (EDCF) (De Vriese et al., 2000).  In particular, 
NO plays an important role in vasodilation.  In 1980, Furchgott and Zawadzki 
described a mediator that is released by the vascular endothelium in response to 
acetylcholine and causes vascular smooth muscle relaxation (Furchgott and Zawadzki, 
1980).  NO is synthesized by three different NO-synthase (NOS) isoforms: inducible 
NOS (iNOS), brain-type (bNOS), and endothelial constitutive NOS (eNOS) (Forstmann 
et al., 1994).  It is generally assumed that these three NOS enzyme isotypes play an 
important role in maintaining proper functions in homeostasis (Bode-Boger et al., 1996; 
Cooke and Tsao, 1997).  However, under chronic proinflammatory conditions, such as 
those at work during arteriosclerosis, local expression of the iNOS isotype is seen in 
endothelia and other cell types (Wilcox et al., 1997).  Furthermore, previous studies 
using pharmacological approaches with muscarinic receptor agonists and antagonists 
suggest that the muscarinic M3 receptor mainly mediates vasodilation via the actions of 
eNOS in the rat aorta (Boulanger et al., 1994; Khurana et al., 2004).  It is well known 
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that the muscarinic M3 receptor is mainly expressed in the endothelium in the aorta.  
However, the extent of the contribution of the muscarinic M3
Cyclohexenonic long-chain fatty alcohol (N-hexacosanol) exhibits a wide variety of 
biological actions.  A previous study showed that N-hexacosanol has neurotrophic 
activation on cultured neurons from the cerebral cortex (Borg et al., 1990).  We have 
reported the ameliorative effects of N-hexacosanol on diabetes-induced hyperreactivity 
of the bladder and trachea in the rat (Satoh et al., 2005; Suzuki et al., 2006; Saito et al., 
2007).  We have also reported that diabetes-induced hypercontraction of the aorta was 
ameliorated by treatment with N-hexacosanol (Kinoshita et al., 2006).  However, the 
effect on hyporelaxation in the aorta is still unknown.  From the above results, we 
hypothesized that N-hexacosanol may have a beneficial effect on the muscarinic M
 receptor to diabetic aortic 
dysfunction is not well known. 
3
 In order to investigate the therapeutic effects of N-hexacosanol on diabetes-induced 
vascular dysfunction and reveal its molecular mechanisms, we conducted organ bath 
studies and quantification of the muscarinic M
 
receptor and on eNOS and iNOS in the diabetes-induced rat aorta.  
3 receptor and eNOS and iNOS mRNA in 
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the rat aorta. 
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2. Materials and Methods 
2.1. Animal model 
All animal experiments were performed in accordance with the guidelines established 
by the Tottori University Committee for Animal Experimentation.  Diabetes was 
induced in 8-week-male Sprague-Dawley rats (SLC, Shizuoka, Japan) by administering 
an intraperitoneal injection of streptozotocin (50 mg/kg) dissolved in 0.1 M 
citrate-phosphate buffer (pH 4.2), according to the method of our previous reports 
(Satoh et al., 2005; Suzuki et al., 2006; Kinoshita et al., 2006; Saito et al., 2007).  The 
rats were divided randomly into 4 age-matched groups (n=6-8).  One group was the 
non-diabetic control (group A), and was administered the vehicle; diabetes was induced 
in the other three groups.  Four weeks after the induction of diabetes, the three groups 
were treated for another 4 weeks with either vehicle (group B) or with N-hexacosanol at 
a daily dose of 2 or 8 mg/kg (groups C and D, respectively).  N-hexacosanol was 
dissolved in ethanol, then a mixture of physiological saline/ Tween 80 was added to 
obtain an ethanol: saline: Tween 80 ratio of 5: 92.15: 2.85 (total volume approximately 
0.3 ml).  The structure of the N-hexacosanol used in this study is shown in Fig. 1.  
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Two days after the injection of streptozotocin or vehicle, the induction of diabetes was 
confirmed by measuring urinary glucose with Pretest 3aⅡ(Wako Pure Chemical, Osaka, 
Japan).  Either N-hexacosanol (groups C and D) or vehicle (groups A and B) was 
injected i.p. every day beginning 4 weeks after the induction of diabetes, according to 
the method used in our previous reports (Satoh et al., 2005; Suzuki et al., 2006; 
Kinoshita et al., 2006; Saito et al., 2007).  All groups were kept under identical 
conditions, with access to food and drinking water ad libitum.  Eight weeks after the 
induction of diabetes, the rats were sacrificed with an overdose of pentobarbital (60 mg 
/ animal, i.p.).  Blood samples were collected from the vena cava, and the aorta was 
removed from each animal and placed in Krebs-Henseleit solution comprised of (mM): 
NaCl 118.0, KCl 4.7, MgSO4 1.2, CaCl2 2.5, KH2PO4 1.2, NaHCO3
 
 24.9, glucose 5.6 
and sodium pyruvate 2.0, for use in functional and biochemical studies. 
2.2. Serum glucose and insulin measurement 
Serum glucose concentrations in the experimental rats were measured by the hexokinase 
method (Glucose CⅡ, Wako Pure Chemical, Osaka, Japan), which was carried out 
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according to the kit manufacturer’s instructions.  Insulin concentrations were also 
measured by ELISA according to the manufacturer’s instructions (Rat Insulin ELISA, 
Mercodia AB, Uppsala, Sweden). 
 
2.3. In vitro organ bath experiments 
Functional studies were performed according to our previous report (Kinoshita et al., 
2006).  The thoracic aortas were cut into approximately 3-mm-long ring segments.  
Each ring was suspended on a wire hook in an organ bath (25 ml) containing 
Krebs-Henseleit solution, and bubbled with 5% CO2 and 95% O2 (37℃).  One hook 
was suspended from a transducer (type 45196A, San-ei Instruments, Tokyo, Japan), and 
the lower hook was fixed to a plastic support leg to a micrometer (Mitutoyo, Tokyo, 
Japan).  Each ring was equilibrated unstretched for 30 minutes.  A load of 0.5 g was 
applied to each ring by micrometer adjustment, and the load was readjusted to this level 
30 minutes later.  Changes in the tone were recorded by a force transducer on a 
personal computer (Macintosh G3, Apple Computer, Cupertino, CA) by use of Chart v 
3.6.9 software and a PowerLab/16sp data acquisition system (AD Instruments, Castle 
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Hill, Australia).  Following a 30-minute period of equilibration, the rings were exposed 
to 100 mM KCl.  In the aorta rings, the contractile response to norepinephrine (1 x 
10-9-3 x 10-6 M) was determined cumulatively.  After a 30-minute washout period, 
propranolol (1 x 10-6 M) was added to prevent the involvement of β-adrenoceptors.  
Endothelium-mediated relaxation was measured as a concentration-response curve to 
acetylcholine (1 x 10-8-3 x10-5 M) in rings precontracted with the submaximal dose of 
norepinephrine (3 x 10-7 M).  Endothelium-independent aortic relaxation in response to 
nitroglycerin (1 x 10-6
 
 M) was also measured in the rings.  
2.4. Real-time polymerase chain reaction (quantification of muscarinic M3
Expressions of muscarinic M
 
receptor, eNOS and iNOS mRNAs) 
3 receptor, eNOS and iNOS mRNAs in the experimental 
aorta were measured by real-time polymerase chain reaction (PCR) methods.  The 
mRNAs were purified by the RNeasy Mini Kit (Quiagen, Valencia, CA) according to 
the manufacturer’s instructions.  A reverse transcriptase mixture (28 µl) containing 2 
µg of total RNA was made and incubated at 37 ℃ for 60 minutes.  Fifteen µl of the 
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master mix was used for the real-time PCR, which was carried out using a LightCycler 
thermal cycler system with a LightCycler-FastStart Hybridization Probe kit according to 
the manufacturer’s instructions (Roche Diagnostics, Tokyo, Japan).  The muscarinic 
M3
 
 receptor (GeneBank Accession: NM_012527) primers and probe sequences were the 
following: primer forward (1227-1245: 5’GGACTGTGGATGTGGAGAG-3’), primer 
reverse (1358-1375: 5’-CGAGGAGTTGGTGTCAGA-3’) and probe forward 
(1267–1284: 5’-CCA GAAGAGCATGGGTGATGGTGACAACT-3’), probe reverse 
(1286–1325: 5’-XGTCAGAAGGATTTCACCAAGC-TTCCCATCCT-3’).  The primer 
and probe of the β-actin (GeneBank Accession: NM_031144) and eNOS (GeneBank 
Accession: AJ011116) and iNOS (GeneBank Accession: D44591) used were from the 
LightCycler-Primer/Probe Set (rat) (Roche Diagnostics, Tokyo, Japan).  A total of 5 µl 
of template was used for the sample.  The specificity of the reaction was confirmed by 
2 % agarose gel electrophoresis.  The primers for the β-actin gene were used as the 
internal standard and gene levels were analyzed by real-time PCR using the same 
reverse transcriptase mixture. 
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2.5. Data analysis 
The data for the contractions induced by norepinephrine were normalized by the 
contractions induced by 100 mM KCl.  The relaxation responses with submaximal 
contraction caused by 3 x 10-7 M norepinephrine were expressed as percentages of 
nitroglycelin.  The ED50 and Emax values were obtained using a Macintosh computer 
(G3) loaded with Chart v3.6.9 software and a PowerLab/16sp data acquisition system.  
The ED50 values were calculated as geometric means, whereas the Emax values were 
calculated as arithmetic means.  The expressions of muscarinic M3
 
 receptor, eNOS and 
iNOS mRNAs were quantified according to the expression of β-actin mRNA in the 
experimental rat aorta.  A statistical comparison of differences between groups was 
performed using analysis of variance and Fisher’s multiple comparison tests.  P<0.05 
was regarded as the level of significance. 
2.6. Drugs and chemicals  
3-(15 Hydroxypentadecyl)-2,4,4-trimethyl-2-cyclohexen 1-one (N-hexacosanol) was 
obtained from Meiji Milk Products Co., Ltd., Tokyo, Japan.  Propranolol and 
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norepinephrine were purchased from Sigma (St. Louis, MO), and nitroglycerin 
(millisrol) was purchased from Nihonkayaku Co., Ltd. (Tokyo, Japan).  
Streptozotocin was purchased from Wako Pure Chemical Co. (Osaka, Japan).  All 
other chemicals were available commercially and of reagent grade. 
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3. Results 
3.1. General features of the experimental animals  
The data obtained for the general features and serum concentrations of insulin and 
glucose in the experimental animals are shown in Table 1.  The diabetic rats that were 
not treated with N-hexacosanol showed no weight gain during the experimental period.  
The diabetic rats displayed significantly higher serum glucose and lower serum insulin 
levels than the control rats.  Treatment with N-hexacosanol (at either 2 or 8 mg/kg) 
neither increased body weight and insulin levels nor reduced serum glucose in the 
diabetic animals.   
 
3.2. Measurement of contraction (A) and relaxation (B) 
A: In the diabetic rat aortic rings, the contraction produced by norepinephrine was 
augmented (Fig. 2A).  With treatment of N-hexacosanol (8 mg/kg), the maximum 
contraction was significantly attenuated toward that obtained using control rat aortic 
rings (Fig. 2A).  The maximum contraction (Emax) and EC50 values are shown in Table 
2. 
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B: The maximum relaxation (Emax) and EC50 values are shown in Table 2.  In the 
aortic rings precontracted by norepinephrine with intact endothelium obtained from all 
groups, the relaxation was produced in a dose-dependent manner (Fig. 2B).  The 
relaxation was markedly reduced in the diabetic aorta (Fig. 2B).  With treatment of 
N-hexacosanol, the attenuated relaxation was recovered; data are shown in Fig. 2B.  
Induction of diabetes significantly increased EC50 values for acetylcholine-induced 
relaxation.  Treatment with either dose of N-hexacosanol, however, did not ameliorate 
these increased EC50
 
 values.  The nitroglycerin-induced relaxation was not changed in 
any groups (Table 2).     
3.3. Measurement of muscarinic M3
Fig. 3 shows the expression of muscarinic M
 receptor, eNOS and iNOS mRNAs in 
the aorta 
3 receptor, eNOS and iNOS mRNAs in the 
aorta.  No significant difference in the eNOS mRNA levels was found between any 
groups while the M3 receptor and iNOS mRNA levels were significantly higher in the 
diabetes than in the control group.  In addition, N-hexacosanol reversed these increases 
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in a dose-dependent manner (Fig. 3). 
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4. Discussion 
  In the diabetic state, the rat aorta exhibited enhanced vascular reactivity to 
norepinephrine and impairment of endothelium-dependent-relaxation by acetylcholine.  
While the eNOS mRNA level was not changed, the muscarinic M3 receptor and iNOS 
mRNA levels were significantly increased in the diabetic aorta.  Although 
N-hexacosanol did not improve the general features or levels of serum glucose and 
insulin in the diabetic rats, it significantly improved the enhanced contraction produced 
by the α1
  Previous reports demonstrated that aortic rings prepared from rats with 
streptozotocin-induced diabetes showed increased contraction in response to 
vasoconstrictor agents and reduced relaxation in response to endothelium-dependent 
relaxant agents, but not to endothelium-independent relaxant agents (Oyama et al., 
1986; Pieper et al., 1998; Kinoshita et al., 2006).  Previously, we demonstrated that 
maximum relaxation in response to nitroglycerin was only around 50 % in Kinoshita’s 
report, while maximum relaxation in response to nitroglycerin exceeded 90 % in this 
-agonist norepinephrine and the impairment of endothelium-dependent 
relaxation induced by acetylcholine in a dose-dependent manner. 
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study (Kinoshita et al., 2006).  In Kinoshita’s reports, submaximal contraction was 
induced by the thromboxane A2 analogue U46619 at a molar dose of 3x10-8, while in 
this experiment, we chose the physiological agonist norepinephrine.  Submaximal 
contraction was induced by norepinephrine at a molar dose of 3x10-7.  The extents of 
contraction produced with agonists were distinct.  The contraction produced by 
U46619 was stronger than that by norepinephrine.  The extent of relaxation by 
nitroglycerin might be smaller than that by norepinephrine (Satoh et al., 1993).  In this 
study, we carefully observed the contractile responses induced by norepinephrine, and 
decided that submaximal contraction was induced by norepinephrine at a molar dose of 
3x10-7.  This may be the reason we obtained maximum relaxation in response to 
nitroglycerin exceeding 90 % in this study.  In this study, although the degree of 
relaxation induced by acetylcholine was significantly improved by the high dose of 
N-hexacosanol, the EC50
 Diabetes mellitus has been reported to induce hyperglycemia and injured vascular 
 values for acetylcholine were not reversed by this dose.  
These data suggest that the affinity of the endothelium for acetylcholine was not 
reversed by treatment with N-hexacosanol.   
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endothelial cells and peripheral nerve cells (Oyama et al., 1986; Ozturk et al., 1996; 
Shinozaki et al., 2003).  Previous studies have shown that N-hexacosanol treatment has 
no effect on serum glucose and insulin levels of diabetic rats (Satoh et al., 2005; Suzuki 
et al., 2006; Kinoshita et al., 2006; saito et al., 2007).  Therefore, the finding that this 
drug does not influence the serum glucose levels indicates that the mechanisms of its 
reversible effect on the diabetic rat aorta do not occur by reducing serum glucose.  
 To clarify the mechanism of the ameliorative effect of N-hexacosanol, we performed 
quantification of muscarinic M3 receptor, eNOS and iNOS mRNAs by real-time PCR. 
In the PCR studies, while the eNOS mRNA level was not changed, the muscarinic M3 
receptor and iNOS mRNA levels exhibited significant increases in the induced diabetic 
aorta.  Previous studies suggested that arterial endothelium cells released acetylcholine 
(Kawashima et al., 1990; Ikeda et al., 1994), and the endothelium dysfunction-induced 
diabetic states might bring about a reduction in acetylcholine release.  Therefore, 
muscarinic M3 receptor mRNA might be upregulated in diabetes.  And, because eNOS 
is expressed in endothelial cells, endothelium dysfunctions reduce the eNOS expression.  
In fact, it has been reported that hyperglycemia and glucose-modified proteins reduce 
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constitutive NOS expression (Chakravarthy et al., 1998).  Bojunga et al reported that 
eNOS mRNA levels were decreased in the diabetic rat aorta (Bojunga et al., 2004).  As 
competitive reverse-transcriptase PCR is more sensitive than real-time PCR, the reasons 
for these different results may be due to the small differences detected by real-time PCR. 
The diabetic status of the animals in other experiments was different from that in ours. 
Furthermore, the muscarinic M3 receptor activation on endothelial cells produces NO 
via eNOS and PGI2 via phospholipase A2 and arachidonic acid (Jaiswal et al., 1991; 
Kan et al., 1995; Maguire and Davenport, 2005; Triggle et al., 2003).  The PG I2 
pathway may be related to this event.  The result obtained for the iNOS mRNA was in 
agreement with that of a previous study (Bojunga et al., 2004).  The results of the 
present study demonstrate that eNOS and iNOS are regulated differentially in 
experimental diabetes mellitus.  Hyperglycemia and glucose-modified proteins may act 
to reduce eNOS activity and at the same time increase iNOS gene expression with 
enhanced NO release.  It is also suggested that hyperglycemia markedly activates the 
βII isoform of protein kinase C (PKC) in endothelial cells by promoting de novo 
synthesis of diacylglycerol (DAG) and increasing mitochondrial superoxide production.  
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Activated PKC can indeed negatively influence transcription of eNOS while acting 
positively on the iNOS gene (Bojunga et al., 2004).  It is known that iNOS is induced 
by inflammation, and that iNOS-derived NO exhibits a powerful protective activity 
towards cellular stress conditions (Buttery et al., 1996).  Moreover, other studies have 
shown that iNOS-derived NO serves to modulate the expression of many different genes 
that also affect protective responses during stress conditions (Ehrt et al., 2001; 
Hemmrich et al., 2003).  It is possible that iNOS does not contribute directly to the 
induction of relaxation, but has other responses protecting the vascular endothelium.  
Previous experimental evidence has suggested that tetrahydrobiopterin (BH4), the 
natural and essential cofactor of NOS, plays a crucial role not only in increasing the rate 
of NO generation by NOS, but also in controlling the formation of superoxide anions 
(O2-) in endothelial cells (Baek et al., 1993).  In fact, oral supplementation with BH4 
restored endothelial function and relieved oxidative tissue damage through the 
activation of eNOS in the aortas of insulin-resistant rats (Pieper et al., 1997; Shinozaki 
et al., 2003).  It is possible that the influence of eNOS-derived NO production on 
hyporelaxation is mediated via other factors or stages.  
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 Jover et al. reported that N-hexacosanol may act directly upon nerve terminals 
inducing Ca2+ entry and hence promote neurohormone release (Jover et al., 2005).  As 
muscarinic M3 receptor subtypes, eNOS and iNOS are expressed in the aortic smooth 
muscle (Ehlert, 2003).  In order to reveal more details and the precise mechanisms of 
this effect, further studies are needed.  Taken together, our data demonstrate that 
N-hexacosanol normalized the dysfunction of relaxation, and reversed diabetes-induced 
upregulation of muscarinic M3
 
 receptor and iNOS mRNAs.  
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Figure legends 
Fig. 1.  The chemical structure of N-hexacosanol used in this study. 
Fig. 2. a) Contractile response of rat aortic rings to norepinephrine.  The data of 
contraction induced norepinephrine were normalized by the KCl (100 mM).  NE: 
norepinephrine.  b) Endothelium-dependent relaxation of rat aortic rings to 
acetylcholine.  The data of relaxation were normalized by the nitroglycerine.  Ach: 
acetylcholine.  A: control rats, B: diabetic rats, C: diabetic rats treated with 
N-hexacosanol (2 mg/kg), and D: diabetic rats treated with N-hexacosanol (8 mg/kg).   
Data are shown as mean ± S.E.M. of six to eight separated determinations in each group. 
*) significantly different from the other groups. **)  Significantly different from B 
group. ***)Significantly different from B and C groups. (p < 0.05) 
Fig. 3. a) Muscarinic M3 receptor mRNA normalized by β-actin. b) eNOS mRNA 
normalized by β-actin. c) iNOS mRNA normalized by β-actin.  A: control rats, B: 
diabetic rats, C: diabetic rats treated with N-hexacosanol (2 mg/kg), and D: diabetic rats 
treated with N-hexacosanol (8 mg/kg).  Data are shown as mean ± S.E.M. of six to 
eight separated determinations in each group.  *) Significantly different from A group. 
Table 1.  General features of the experimental rats 
          Body Weight (g)    
      8 weeks old 12 weeks old   16 weeks old    Serum glucose (mg/dl)     Serum insulin (µg/l)      
A 242.9 ± 3.0 423.6 ± 5.9 498.8 ± 10.1  172.8 ± 13.9 2.39 ± 0.660  
B 246.8 ± 6.4 259.5 ± 17.2 a 231.8 ± 23.5 a 405.0 ± 54.3 a 0.17 ± 0.009 a
C 250.4 ± 4.7 251.0 ± 17.0 
  
a 229.0 ± 25.4 a 314.4 ± 46.9 a 0.17 ± 0.010 a
D 253.3 ± 5.1 257.0 ± 16.1 
  
a 237.0 ± 17.1 a 364.8 ± 34.3 a 0.16 ± 0.004 
 
a 
A: control rats, B: diabetic rats treated with sham, C: diabetic rats treated with N-hexacosanol (2 mg/kg), and D: diabetic rats treated 
with N-hexacosanol (8 mg/kg).  Data are shown as mean ± S.E.M. of six to eight separated determinations in each group.  a) 
Significantly different from the A group.   
Table 2. Data of functional studies in the rat aorta   
     Contraction              Relaxation 
        Noeepinephr ine                                   Acetylcholine                        Nitroglycer in   
 Emax /KCl (100 mM)   EC50 ( e-8 M )    Maximum relaxation ( %  )      EC50
A 1.67±0.03 3.58±0.70 68.26±3.14           0.54±0.07   91.76±2.54 
( e-7 M )      Maximum relaxation ( %  )       
B 2.15±0.08 a 2.74±0.81 29.81±6.15 a          2.28±0.67 a 
C 2.04±0.13 
  96.46±2.03 
a 3.09±0.77 27.36±4.89 a            2.10±0.44 a   
D 1.86±0.10 
95.92±2.42 
a, b 3.64±1.22 53.52±4.84 a, c         2.68±0.49 a
A: control rat, B:diabetic rat, C: diabetic rat with treatment with N-hexacasanol (2mg/kg), and D: diabetic rat with treatment with N-hexacosanol (8mg/kg).  The relaxation 
responses with submaximal contraction caused by 3 x 10
   97.17±1.18 
-7 M norepinephrine were expressed as percentages of nitroglycelin.  Emax and EC50 values under contraction are for 
norepinephrine.  Maximum relaxation and EC50 values are for acetylcholine in aorta precontracted with norepinephrine.  The relaxation responses to nitroglycerine as the 
percentage of the submaximum contraction obtained with norepinephrine.  Data are shown as mean± S.E.M. of six to eight separated determinations in each 
group.  a)Significantly different from A group.  b)Significantly different from B group. c)Significantly different from B and C groups. (p < 0.05) 
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Figure 2. Measurement of contraction and relaxation
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Figure 3. Expression of mRNAs in the rat
aorta
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